Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01373489 · ClinicalTrials.gov registry record · NA

Technology-assisted Case Management in Adults With Type 2 Diabetes

A NA study of Diabetes, sponsored by State University of New York at Buffalo.

Completed
Registry status
NA
Development phase
113
Enrollment target
1
Study location

NCT01373489 is a NA study of Diabetes that has completed, run by State University of New York at Buffalo. The registered enrollment target is 113 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01373489, a NA study of Diabetes, has completed, sponsored by State University of New York at Buffalo.

COMPLETED
Registry status
NA
Development phase
113 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to help low income patients achieve and maintain better self-management skills and improve blood sugar levels, using a 2-in-1 blood glucose and blood pressure monitoring system and nurse case management. Patients must be served at a Federally Qualified Health Center (FQHC) in coastal South Carolina.

Conditions Studied

Interventions

  • BEHAVIORAL Technology-Assisted Case Management

Study Locations (1)

South Carolina

  • Franklin C. Fetter Family Health Center, Inc. - Charleston

Trial Details

FieldValue
Enrollment Target 113 participants
Start Date 2011-07
Est. Completion 2016-06
Phase NA

What the Registry Record Tells You About NCT01373489

The ClinicalTrials.gov registry entry for NCT01373489 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Technology-Assisted Case Management is the first listed.

NCT01373489 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT01373489 about?

NCT01373489 is a clinical study titled "Technology-assisted Case Management in Adults With Type 2 Diabetes". The purpose of this study is to help low income patients achieve and maintain better self-management skills and improve blood sugar levels, using a 2-in-1 blood glucose and blood pressure monitoring system and nurse case management. Patients must be served at a Federally Qualified Health Center (FQH...

What is the current status of trial NCT01373489?

This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2011-07. Estimated completion is 2016-06.

What conditions does trial NCT01373489 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT01373489?

The interventions under investigation include: Technology-Assisted Case Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT01373489?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01373489 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.